We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

28 hedge funds and large institutions have $5.94M invested in Zomedica Corp. in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

145% more capital invested

Capital invested by funds: $2.43M → $5.94M (+$3.51M)

75% more funds holding

Funds holding: 16 → 28 (+12)

Holders
28
Holders Change
+12
Holders Change %
+75%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.46M
2
Millennium Management
Millennium Management
New York
+$187K
3
BlackRock
BlackRock
New York
+$177K
4
Northern Trust
Northern Trust
Illinois
+$133K
5
Barclays
Barclays
United Kingdom
+$117K

Top Sellers

Rank Fund Capital Flow
1
IP
Isthmus Partners
Wisconsin
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
1
Cambridge Investment Research Advisors
Iowa
$2.92M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.9M +$1.46M +7,669,566 +2,602%
Millennium Management
3
Millennium Management
New York
$234K +$187K +983,512 New
BlackRock
4
BlackRock
New York
$221K +$177K +930,154 New
Northern Trust
5
Northern Trust
Illinois
$167K +$133K +700,163 New
Barclays
6
Barclays
United Kingdom
$146K +$117K +614,450 New
Citadel Advisors
7
Citadel Advisors
Florida
$128K +$99K +519,470 +3,140%
CCFM
8
Clear Creek Financial Management
Washington
$95K +$76.2K +400,000 New
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$44K +$35.3K +185,168 New
JA
10
JVL Associates
Michigan
$14K – – –
RFA
11
Reilly Financial Advisors
California
$14K +$11.4K +59,600 New
UBS Group
12
UBS Group
Switzerland
$13K +$900 +4,727 +9%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$12K +$9.84K +51,640 New
Victory Capital Management
14
Victory Capital Management
Texas
$8K +$1.49K +7,806 +32%
RIS
15
Retirement Income Solutions
Michigan
$7K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$6K +$3.81K +20,000 +333%
VFA
17
Voya Financial Advisors
Connecticut
$3K – – –
HighTower Advisors
18
HighTower Advisors
Illinois
$3K +$2.67K +14,000 New
ECM
19
ETrade Capital Management
Virginia
$3K +$2.68K +14,091 New
Creative Planning
20
Creative Planning
Kansas
$2K – – –
S
21
SignatureFD
Georgia
$2K +$1.72K +9,000 New
KF
22
Krilogy Financial
Missouri
$2K +$1.91K +10,000 New
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1K – – –
CAPTRUST Financial Advisors
24
CAPTRUST Financial Advisors
North Carolina
$1K +$828 +4,346 New
RCA
25
Ranch Capital Advisors
Florida
$1K +$1.91K +10,000 New
1
2

ZOM Hedge Fund Activity: Q2 2020 in Review

28 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2020, worth a combined $5.94M — up 145% from $2.43M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ZOM positions and 2 closed out — a net gain of 12 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.46M. The largest seller was Isthmus Partners, exiting entirely with an estimated $6K sold.

  • 28 institutional investors held Zomedica Corp. (ZOM) as of Q2 2020, up from 16 in Q1 2020.
  • Funds reported $5.94M of Zomedica Corp. stock for Q2 2020, up 145% quarter-over-quarter.
  • 14 funds opened new Zomedica Corp. positions in Q2 2020 and 2 closed out, a net change of +12 holders.
  • The largest Zomedica Corp. buyer in Q2 2020 was Vanguard Group, an estimated $1.46M added.
  • The largest Zomedica Corp. seller in Q2 2020 was Isthmus Partners, an estimated $6K sold.

Based on aggregated 13F filings for Q2 2020.